Soliris - eculizumab
Navigation: NDC > Supplier starting with: A > ALEXION PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 25682-001 |
| Proprietary Name: | Soliris |
| Suffix: | |
| Non-Proprietary Name: | eculizumab |
| Dosage Form: | INJECTION, SOLUTION, CONCENTRATE |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 02-04-2007 |
| Category Name: | BLA |
| Application Number: | BLA125166 |
| Labeler: | ALEXION PHARMACEUTICALS INC. |
| Substance Name: | ECULIZUMAB |
| Active Numerator Strength: | 300 |
| Active Ingredient Unit: | mg/30mL |
| Pharm Classes: | Complement Inhibitor [EPC],Complement Inhibitors [MoA] |
| DEA Schedule: |